CD147 Expression Indicates Unfavourable Prognosis in Prostate Cancer
- 186 Downloads
Extracellular matrix metalloproteinase inducer (EMMPRIN, also named as CD147) is a multifunctional membrane glycoprotein over-expressed in many kinds of human solid tumors. It has been demonstrated to be involved in tumor invasion and angiogenesis. The aim of this study was to analyze the clinicopathological characteristics of the expression of CD147 in human prostate cancer (PCa), and to evaluate its clinical significance in the histologic classification and prognosis of PCa. CD147 protein expression in paraffin-embedded specimens gathered from 62 cases of PCa and 30 cases of benign prostatic hyperplasia (BPH) were detected by the method of immunohistochemistry. The association of CD147 protein expression with the clinicopathological characteristics and with the prognosis of PCa was subsequently assessed. CD147 expression were positively expressed in 51/62 (82.3%) of PCa and 4/30 (13.3%) of BPH cases, respectively. The positive expression rate of CD147 in PCa tissues was significantly higher than that in BPH. The positive expression of CD147 was dramatically associated with TNM grade (p < 0.001), the depth of the prostatic wall invasion (p = 0.008), GLEASON Score (p = 0.001) and Histologic grade (p = 0.001). The patients with CD147 expression were associated with a poor prognosis of PCa (p = 0.01) and the survival rate of the patients with a strong positive expression of CD147 was the lowest (p = 0.01). The results suggest that the expression of CD147 may be an important feature of PCa and the detection of its expression may benefit us in the prediction of the prognosis of PCa.
KeywordsProstate cancer CD147 Clinical pathology Diagnosis Prognosis
This work was supported by grants from the Natural Science Foundation of Guangdong Province (No.04003650) and the Key Programs of Science and Technology of Guangzhou city (No. 200323 – E4053) and National High Technology Research and Development Project of China (No.2006AA02A245).
- 6.Wang L, Wu G, Yu L, Yuan J, Fang F, Zhai Z et al (2006) Inhibition of CD147 expression reduces tumor cell invasion in human prostate cancer cell line via rna interference. Cancer Biology & Therapy 5:608–614Google Scholar
- 8.Li Y, Shang P, Qian A et al (2003) Inhibitory effects of antisense RNA of HAb18G/CD147 on invasion of hepatocellular carcinoma cells in vitro. World J Gastroente 9:2174–2177Google Scholar
- 25.Lanyi M, Antonescu CR (2002) The precrystalline cytoplasmic granules of alveolar soft part sarcoma contain monocarboxylate transporter 1 and CD147. Am J Pathol 160:1215–1221Google Scholar
- 26.Seitz C, Djavan B (2006) Biological markers of prostate cancer. Ann Urol (Paris). 40:329–335Google Scholar